Paraquat Inhibits Autophagy Via Intensifying the Interaction Between HMGB1 and α-Synuclein
- PMID: 35316522
- DOI: 10.1007/s12640-022-00490-x
Paraquat Inhibits Autophagy Via Intensifying the Interaction Between HMGB1 and α-Synuclein
Abstract
Paraquat, a widely used herbicide, is associated with an increased risk of Parkinson's disease (PD). PQ induces upregulation and accumulation of α-synuclein in neurons, which is one of the major pathological hallmarks of PD. Autophagy, as the major mechanism for the clearance of α-synuclein, is disrupted upon pesticide exposure as well as in PD patients. Meanwhile, HMGB1 is involved in autophagy dysfunction and particularly relevant to PD. However, whether PQ exposure affects HMGB1, α-synuclein, and autophagy function have rarely been reported. In this study, we found that PQ exposure impaired autophagy function via disturbing the complex formation of HMGB1 and Beclin1. Moreover, the expression of α-synuclein is modulated by HMGB1 and the interaction between HMGB1 and α-synuclein was intensified by PQ exposure. Taken together, our results revealed that HMGB1-mediated α-synuclein accumulation could competitively perturb the complex formation of HMGB1 and Beclin1, thereby inhibiting the autophagy function in SH-SY5Y cells.
Keywords: Autophagy; Beclin1; HMGB1; Paraquat; Parkinson’s disease; α-Synuclein.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease.Curr Pharm Biotechnol. 2024;25(8):937-943. doi: 10.2174/1389201025666230905092218. Curr Pharm Biotechnol. 2024. PMID: 37670710 Review.
-
[Autophagic dysfunction contributes to α-synuclein accumulation in dopaminergic neurons induced by paraquat].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Mar 20;38(3):180-186. doi: 10.3760/cma.j.cn121094-20190924-00543. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020. PMID: 32306690 Chinese.
-
Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells.Diagn Pathol. 2016 Jan 29;11:15. doi: 10.1186/s13000-016-0459-5. Diagn Pathol. 2016. PMID: 26822891 Free PMC article.
-
HMGB1 promotes the starvation-induced autophagic degradation of α-synuclein in SH-SY5Y cells Atg 5-dependently.Life Sci. 2018 Jun 1;202:1-10. doi: 10.1016/j.lfs.2018.03.031. Epub 2018 Mar 15. Life Sci. 2018. PMID: 29551576
-
Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease.Int J Mol Sci. 2022 Feb 21;23(4):2378. doi: 10.3390/ijms23042378. Int J Mol Sci. 2022. PMID: 35216492 Free PMC article. Review.
Cited by
-
Pesticide-Induced Inflammation at a Glance.Toxics. 2023 Oct 31;11(11):896. doi: 10.3390/toxics11110896. Toxics. 2023. PMID: 37999548 Free PMC article. Review.
-
MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.Neurochem Res. 2024 Jul;49(7):1677-1686. doi: 10.1007/s11064-024-04130-y. Epub 2024 Mar 7. Neurochem Res. 2024. PMID: 38451434 Free PMC article.
-
Interrelationship between PQ exposure and Parkinson disease: A systematic review and meta-analysis.Medicine (Baltimore). 2025 Jun 13;104(24):e42796. doi: 10.1097/MD.0000000000042796. Medicine (Baltimore). 2025. PMID: 40527812 Free PMC article.
-
Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson's Disease with Potential Therapeutic Implications.Biomolecules. 2025 Jan 19;15(1):149. doi: 10.3390/biom15010149. Biomolecules. 2025. PMID: 39858542 Free PMC article. Review.
-
High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease.Curr Pharm Biotechnol. 2024;25(8):937-943. doi: 10.2174/1389201025666230905092218. Curr Pharm Biotechnol. 2024. PMID: 37670710 Review.
References
-
- Bell CW et al (2006) The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291(6):C1318–C1325 - DOI
-
- Bertram L, Tanzi RE (2005) The genetic epidemiology of neurodegenerative disease. J Clin Invest 115(6):1449–1457 - DOI
-
- Brichta L, Greengard P (2014) Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update. Front Neuroanat 8:152 - DOI
-
- Cook C, Stetler C, Petrucelli L (2012) Disruption of protein quality control in Parkinson’s disease. Cold Spring Harb Perspect Med 2(5):a009423 - DOI
-
- Dai H et al (2015) PINK1/Parkin-mediated mitophagy alleviates chlorpyrifos-induced apoptosis in SH-SY5Y cells. Toxicology 334:72–80 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical